Fuling Yunhua Granules (Beijing Supreme Life Pharmaceutical Technology Co., Ltd.)

Fuling Yunhua Granules is a Traditional Chinese Medicine (TCM) botanical formulation developed by Beijing Supreme Life Pharmaceutical Technology. It is currently being evaluated in Phase 2 clinical trials for the treatment of type 2 diabetes mellitus (T2DM), specifically in patients with poor glycemic control following diet and exercise interventions. The drug is typically studied as part of a sequential therapy regimen in combination with Dihuang Baoyuan Granules (Prescription B). As a complex herbal extract, its therapeutic mechanism likely involves multi-target metabolic regulation characteristic of TCM, though specific molecular targets have not been formally defined in clinical documentation.